1.9(top 9%)
Impact Factor
2.1(top 9%)
extended IF
57(top 7%)
H-Index
940
authors
2.2K
papers
26.8K
citations
2.6K
citing journals
16.3K
citing authors

Most Cited Articles of Applied Immunohistochemistry and Molecular Morphology

TitleYearCitations
KIT (CD117): a review on expression in normal and neoplastic tissues, and mutations and their clinicopathologic correlation2005372
Development of a Companion Diagnostic PD-L1 Immunohistochemistry Assay for Pembrolizumab Therapy in Non-Small-cell Lung Cancer2016197
Sox10 and S100 in the diagnosis of soft-tissue neoplasms2012195
Recommendations for improved standardization of immunohistochemistry2007170
Expression of PAX8 in normal and neoplastic tissues: a comprehensive immunohistochemical study2011162
Microsatellite Instability: A Predictive Biomarker for Cancer Immunotherapy2018159
Development of an automated PD-L1 immunohistochemistry (IHC) assay for non-small cell lung cancer2015138
The diagnostic value of TTF-1, CK 5/6, and p63 immunostaining in classification of lung carcinomas2007134
P63 expression in lung carcinoma: a tissue microarray study of 408 cases2004133
Localization of mesothelin in epithelial ovarian cancer2005130
Survivin expression quantified by Image Pro-Plus compared with visual assessment2009127
Comparison of thyroid transcription factor-1 expression by 2 monoclonal antibodies in pulmonary and nonpulmonary primary tumors2010117
Thyroid transcription factor-1: a review2002116
Diagnostic value of CDX-2 and TTF-1 expressions in separating metastatic neuroendocrine neoplasms of unknown origin2007114
Paired Comparison of PD-L1 Expression on Cytologic and Histologic Specimens From Malignancies in the Lung Assessed With PD-L1 IHC 28-8pharmDx and PD-L1 IHC 22C3pharmDx2017109
Value of thyroid transcription factor-1 immunostaining in tumor diagnosis: a review and update2012107
Consensus recommendations on estrogen receptor testing in breast cancer by immunohistochemistry2008106
HER2 expression in gastric and gastroesophageal junction adenocarcinoma in a US population: clinicopathologic analysis with proposed approach to HER2 assessment201297
Comparison of quantification of histochemical staining by hue-saturation-intensity (HSI) transformation and color-deconvolution200397
Development of a PD-L1 Complementary Diagnostic Immunohistochemistry Assay (SP142) for Atezolizumab201997
The use of Cytokeratin 19 (CK19) immunohistochemistry in lesions of the pancreas, gastrointestinal tract, and liver201092
MGMT immunohistochemical expression and promoter methylation in human glioblastoma200892
CD79: a review200191
SOX10 expression in malignant melanoma, carcinoma, and normal tissues201390
Comparison of Different Antibody Clones for Immunohistochemistry Detection of Programmed Cell Death Ligand 1 (PD-L1) on Non-Small Cell Lung Carcinoma201888